This model outlines how the administration plans to explore expanding access to obesity care with certain GLP-1 medications for people enrolled in Medicare and Medicaid
This is the timeframe from the Finkley study (improved laxity, firmness, wrinkle depth) and the Carey/Pickart ultrasound study (28% average collagen density increase)
Tirzepatide (Mounjaro) is a highly effective weight loss treatment for individuals with a body mass index (BMI) of 30 or above, or those with a BMI of 27 or higher who also have conditions like type 2 diabetes, high blood pressure, or elevated cholesterol levels
Dysfunctional detoxification pathways can lead to liver damage, DNA damage and increased cellular stress.4
Where clinically appropriate, NAD+ may be combined with L-glutathione as part of a structured treatment plan following consultation
Andrew Huberman: But I have a family member, I'll just mention this, I have a family member who was not feeling well, just kind of feeling off, a little low, had some digestive issues
